Clinical trial
AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or…
NCT00390117 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00390117 |
|---|---|
| Title | AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma |
| Official title | A Phase I Study of AT7519M Given Twice Weekly in Patients With Advanced Incurable Malignancy |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | CDKI AT7519, laboratory biomarker analysis |
| Enrollment | 34 |
| Start date | Jan 5, 2007 |
| Primary completion | Mar 13, 2012 |
| Completion | Jan 10, 2013 |
| First posted | Oct 19, 2006 |
| Last update posted | Aug 4, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: